Home / Current Issue / Paper 1719132
AI-Powered Risk Assessment and Prediction Models for VTE: A Narrative Review
Subject area: Biological & Medical Sciences · Area of research: Venous thromboembolism
DOI: 10.64388/IREV9I12-1719132
Abstract
Background: A major avoidable cause of illness and death in healthcare settings worldwide is venous thromboembolism (VTE). While there are conventional risk assessment methods, the capacity of AI and ML techniques to evaluate complicated, multidimensional clinical data and detect non-linear patterns that conventional statistical methods could overlook makes them attractive alternatives to traditional VTE risk classification methods. Objective: This narrative review synthesises evidence on the performance, feasibility, implementation, and contextual relevance of AI-powered VTE risk assessment models. Methods: A comprehensive narrative review was undertaken on PubMed, Google Scholar, ScienceDirect, and Web of Science for 2010–2025 research on AI and VTE. For VTE prediction or diagnosis, included research created, validated, or deployed AI/ML models such supervised learning algorithms, ensemble approaches, and deep learning architectures. Studies using standard statistical techniques or without performance indicators were eliminated. The narrative synthesis centred on the model's performance, the experiences of clinical application, and the obstacles to acceptance. Results: Traditional risk assessments were routinely surpassed by AI models across a variety of clinical groups. Deep neural networks, gradient boosting, and random forests all showed very good VTE prediction accuracy. Despite this, there are still a lot of obstacles to overcome, such as a lack of external validation, uneven performance among populations, a large number of false positives, restrictions on data quality, and inadequate infrastructure. Conclusion: Models driven by AI show great potential for enhancing personalised risk assessment and early VTE identification. Factoring in the challenges and shortcomings is crucial for effective use.
Keywords
Artificial Intelligence, Machine Learning, Deep Vein Thrombosis, Risk Prediction, Clinical Decision Support.
References
[1] Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2023;20(4):248-62.
[2] Degefa W, Woldu MA, Mekonnen D, Berha AB. Risk, incidence and predictors of venous thromboembolism among patients attending the emergency department of tertiary care hospitals in Addis Ababa city, Ethiopia: a multicentre prospective study. BMJ Open. 2025;15(1): e091364.
[3] Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2021 update: a report from the American Heart Association. Circulation. 2021;143(8): e254-e743.
[4] Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. Venous thromboembolism (VTE) in Europe. Thromb Haemost. 2007;98(10):756-64.
[5] Kahn SR, Diendéré G, Morrison DR, Piché A, Filion KB, Klil-Drori AJ, et al. Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019;9(5): e024444.
[6] Pandor A, Tonkins M, Goodacre S, Sworn K, Clowes M, Griffin XL, et al. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review. BMJ Open. 2021;11(7): e045672.
[7] Okoye H, Nwagha T, Ezigbo E, Nnachi O, Obodo O, Nnachi O, et al. Low awareness of venous thromboembolism among the general population: a call for increased public enlightenment programs. J Prev Med Hyg. 2021;62(3): E704.
[8] Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg. 2010;199(1): S3-10.
[9] Chiasakul T, Lam BD, McNichol M, Robertson W, Rosovsky RP, Lake L, et al. Artificial intelligence in the prediction of venous thromboembolism: a systematic review and pooled analysis. Eur J Haematol. 2023;111(6):951-62.
[10] Kopp SL, Vandermeulen E, McBane RD, Perlas A, Leffert L, Horlocker T. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines. Reg Anesth Pain Med. 2025.
[11] Patel H, Sun H, Hussain AN, Vakde T. Advances in the diagnosis of venous thromboembolism: a literature review. Diagnostics. 2020;10(6):365.
[12] Gupta A, Lam BD, Zerbey S, Rosovsky RP, Lake L, Dodge L, et al. Artificial intelligence meets venous thromboembolism: informaticians’ insights on diagnosis, prevention, and management. Blood Vessels Thromb Hemost. 2024;1(4):100031.
[13] Wang Q, Yuan L, Ding X, Zhou Z. Prediction and diagnosis of venous thromboembolism using artificial intelligence approaches: a systematic review and meta-analysis. Clin Appl Thromb Hemost. 2021; 27:10760296211021162.
[14] Cadena Zepeda AA, García-Guerrero EE, Aguirre-Castro OA, Galindo-Aldana GM, Juárez-Ramírez R, Gómez-Guzmán MA, et al. Machine learning-based approaches for early detection and risk stratification of deep vein thrombosis: a systematic review. Eng. 2025;6(9):243.
[15] Gil MR, Pantanowitz J, Rashidi HH. Venous thromboembolism in the era of machine learning and artificial intelligence in medicine. Thromb Res. 2024; 242:109121.
[16] Younis HA, Eisa TAE, Nasser M, Sahib TM, Noor AA, Alyasiri OM, et al. A systematic review and meta-analysis of artificial intelligence tools in medicine and healthcare: applications, considerations, limitations, motivation and challenges. Diagnostics. 2024;14(1):109.
[17] Onwuzo C, Olukorode J, Sange W, Tanna SJ, Osaghae OW, Hassan A, et al. A review of the preventive strategies for venous thromboembolism in hospitalized patients. Cureus. 2023;15(11).
[18] Guan C, Ma F, Chang S, Zhang J. Interpretable machine learning models for predicting venous thromboembolism in the intensive care unit: analysis based on data from 207 centers. Crit Care. 2023;27(1):406.
[19] Jin J, Lu J, Su X, Xiong Y, Ma S, Kong Y, et al. Development and validation of an ICU-venous thromboembolism prediction model using machine learning approaches: a multicenter study. Int J Gen Med. 2024;3279–92.
[20] Chen X, Hou M, Wang D. Machine learning-based model for prediction of deep vein thrombosis after gynecological laparoscopy: a retrospective cohort study. Medicine. 2024;103: e36717.
[21] Martins TD, Annichino-Bizzacchi JM, Romano AVC, Maciel Filho R. Artificial neural networks for prediction of recurrent venous thromboembolism. Int J Med Inform. 2020; 141:104221.
[22] Dalil D, Esmaeili S, Safaee E, Asgari S, Kejani N. The prediction of venous thromboembolism using artificial intelligence and machine learning in lower extremity arthroplasty: a systematic review. Arthroplasty Today. 2025; 33:101672.
[23] Zhou S, Ma X, Jiang S, Huang X, You Y, Shang H, et al. A retrospective study on the effectiveness of artificial intelligence-based clinical decision support system to improve incidence of hospital-related venous thromboembolism. Ann Transl Med. 2021;9(6):491.
[24] Gu Y, Yang Y, Gao X, Wang Y, Yang L, Wei Y. Application of artificial intelligence in risk assessment and management of venous thromboembolism: scoping review. Front Physiol. 2025; 16:1664470.
[25] Jiang Y, Li A, Li Z, Li Y, Li R, Zhao Q, et al. Leveraging machine learning for enhanced and interpretable risk prediction of venous thromboembolism in acute ischemic stroke care. PLoS One. 2025;20(3): e0302676.
[26] Hou T, Qiao W, Song S, Guan Y, Zhu C, Yang Q, et al. Use of machine learning techniques to predict deep vein thrombosis in rehabilitation inpatients. Clin Appl Thromb Hemost. 2023; 29:10760296231179438.
[27] Yumei Q, Liandi J, Chunming Q, Jiangbo W, Haiqing Z. A study on the risk prediction model for venous thromboembolism in orthopedic inpatients based on machine learning. Front Med. 2025; 12:1574546.
[28] Huang X, Zhou S, Ma X, Jiang S, Xu Y, You Y, et al. Effectiveness of an artificial intelligence clinical assistant decision support system to improve incidence of hospital-associated venous thromboembolism: a prospective randomised controlled study. BMJ Open Qual. 2023;12(4): e002267.
[29] Contreras-Luján EE, García-Guerrero EE, López-Bonilla OR, Tlelo-Cuautle E, López-Mancilla D, Inzunza-González E. Evaluation of machine learning algorithms for early diagnosis of deep venous thrombosis. Math Comput Appl. 2022;27(2):24.
[30] Mora D, Nieto JA, Mateo J, Bikdeli B, Barco S, Trujillo-Santos J, et al. Machine learning to predict outcomes in patients with acute pulmonary embolism who prematurely discontinued anticoagulant therapy. Thromb Haemost. 2022;122(4):570–7.
[31] Nafee T, Gibson CM, Travis R, Yee MK, Kerneis M, Chi G, et al. Machine learning to predict venous thrombosis in acutely ill medical patients. Res Pract Thromb Haemost. 2020;4(2):230–7.
[32] Sheng W, Wang X, Xu W, Hao Z, Ma H, Zhang S. Development and validation of machine learning models for venous thromboembolism risk assessment at admission: a retrospective study. Front Cardiovasc Med. 2023; 10:1198526.
[33] El-Bouri WK, Sanders A, Lip GY. Predicting acute and long-term mortality in pulmonary embolism patients using machine learning. Eur J Intern Med. 2023; 118:42–8.
[34] Ziyadah MS, Mansory EM, Alahwal HM, Bahashwan SM, Almohammadi AT, Radhwi OO, et al. Predisposing factors and incidence of venous thromboembolism among hospitalized patients with sickle cell disease. J Clin Med. 2023;12(20):6498.
[35] Kuan YKI, Kok YJ, Liu NSH, Ong BJA, Chee YJ, Xu C, et al. Artificial intelligence in clinical thrombosis and hemostasis: a review. Res Pract Thromb Haemost. 2025;9(5):102984.
[36] Grdinic AG, Radovanovic S, Gleditsch J, Jørgensen CT, Asady E, Pettersen HH, et al. Developing a machine learning model for bleeding prediction in cancer-associated thrombosis receiving anticoagulation therapy. J Thromb Haemost. 2024;22(4):1094–1104.
[37] Muñoz Martín AJ, Lecumberri R, Souto JC, Obispo B, Sanchez A, Aparicio J, et al. Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing. Clin Transl Oncol. 2025;27(4):1816–25.
[38] Gerke S, Minssen T, Cohen G. Ethical and legal challenges of artificial intelligence-driven healthcare. In: Artificial Intelligence in Healthcare. Academic Press; 2020. p. 295–336.
[39] Parikh RB, Teeple S, Navathe AS. Addressing bias in artificial intelligence in health care. JAMA. 2019;322(24):2377–8.
[40] Lam BD, Dodge LE, Zerbey S, Robertson W, Rosovsky RP, Lake L, et al. The potential use of artificial intelligence for venous thromboembolism prophylaxis and management: clinician and healthcare informatician perspectives. Sci Rep. 2024;14(1):12010.
[41] Weiner EB, Dankwa-Mullan I, Nelson WA, Hassanpour S. Ethical challenges and evolving strategies in integrating artificial intelligence into clinical practice. PLOS Digit Health. 2025;4(4): e0000810.
[42] Al Raizah A, Alrizah M. Artificial intelligence in thrombosis: transformative potential and emerging challenges. Thromb J. 2025;23(1):2.
[43] Liu S, Zhang F, Xie L, Wang Y, Xiang Q, Yue Z, et al. Machine learning approaches for risk assessment of PICC-related vein thrombosis in hospitalized cancer patients. Int J Med Inform. 2019; 129:175–83.
[44] Trist ER, Emery F. Sociotechnical systems theory. In: Organizational Behavior 2. Routledge; 2015. p. 169–94.
[45] Trist EL, Bamforth KW. Some social and psychological consequences of the longwall method of coal-getting. 1951.
[46] Borella P, Bargellini A, Marchegiano P, Vecchi E, Marchesi I. Narrative review. Ann Ig. 2016; 28:98–108.
How to cite this paper
@article{1719132,
author = {AKANDE Itunu Adedapo , OGUNKORODE Agatha Olufunke , ADEGBILERO-IWARI Oluwaseun Eniola , JEMILUGBA Margaret O. },
title = {AI-Powered Risk Assessment and Prediction Models for VTE: A Narrative Review},
journal = {Iconic Research And Engineering Journals},
year = {2026},
volume = {9},
number = {12},
pages = {2593-2602},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1719132.pdf},
abstract = {Background: A major avoidable cause of illness and death in healthcare settings worldwide is venous thromboembolism (VTE). While there are conventional risk assessment methods, the capacity of AI and ML techniques to evaluate complicated, multidimensional clinical data and detect non-linear patterns that conventional statistical methods could overlook makes them attractive alternatives to traditional VTE risk classification methods. Objective: This narrative review synthesises evidence on the performance, feasibility, implementation, and contextual relevance of AI-powered VTE risk assessment models. Methods: A comprehensive narrative review was undertaken on PubMed, Google Scholar, ScienceDirect, and Web of Science for 2010–2025 research on AI and VTE. For VTE prediction or diagnosis, included research created, validated, or deployed AI/ML models such supervised learning algorithms, ensemble approaches, and deep learning architectures. Studies using standard statistical techniques or without performance indicators were eliminated. The narrative synthesis centred on the model's performance, the experiences of clinical application, and the obstacles to acceptance. Results: Traditional risk assessments were routinely surpassed by AI models across a variety of clinical groups. Deep neural networks, gradient boosting, and random forests all showed very good VTE prediction accuracy. Despite this, there are still a lot of obstacles to overcome, such as a lack of external validation, uneven performance among populations, a large number of false positives, restrictions on data quality, and inadequate infrastructure. Conclusion: Models driven by AI show great potential for enhancing personalised risk assessment and early VTE identification. Factoring in the challenges and shortcomings is crucial for effective use.},
keywords = {Artificial Intelligence, Machine Learning, Deep Vein Thrombosis, Risk Prediction, Clinical Decision Support.},
month = {June},
doi = {https://doi.org/10.64388/IREV9I12-1719132}
}